IP Group plc is a London-listed investor that turns university science into companies. Founded in 2001 and listed on the London Stock Exchange, it does not behave like a conventional venture fund: it signs long-term partnerships with research-intensive universities, then builds, funds and supports spin-out companies from their laboratories over many years.

The thesis is that breakthrough science needs patient, hands-on capital. IP Group offers more than venture funding, providing business-building expertise, networks, recruitment and business support to companies commercialising intellectual property. Its sectors are life sciences, deeptech and cleantech, spanning early-stage spin-outs through to mature listed businesses.

Stages run from company formation to follow-on rounds and public markets. IP Group invests from its own balance sheet and through managed funds. In its 2025 annual results it reported managing or advising £557m, of which around two-thirds, £379m, is managed by Parkwalk, its specialist EIS fund management subsidiary. Parkwalk invested £20.6m in 2025 across 27 companies in the university spin-out sector.

A single headline fund size is not publicly disclosed, because IP Group operates as a listed group with balance-sheet capital plus multiple managed funds, including funds run with the universities of Oxford, Cambridge, Bristol and Imperial College London, and a newer EIS fund with Northern Gritstone covering Leeds, Liverpool, Manchester and Sheffield.

Notable portfolio companies include Oxford Nanopore Technologies, the DNA sequencing company; First Light Fusion; Hysata; and Oxa. Recent deals show the model in action: OXCCU, an Oxford spin-out turning waste carbon into sustainable aviation fuel, closed a £20.75m Series B in which IP Group committed £2m from its balance sheet and £2m from managed funds; and Matter Machine, an AI materials-discovery spin-out from the University of Liverpool, raised a £4m round led by IP Group. The group is led by chief executive Greg Smith.

Programmes run through its university partnerships and through Parkwalk, which Beauhurst data cited by the group ranks as by far the UK's leading investor in the university spin-out sector. IP Group has also committed capital internationally, including a $200 million, ten-year commercialisation agreement with Australia's Group of Eight universities and the University of Auckland.

How to apply for funding

There is no public application portal for founders. IP Group invests through its partner universities, so the real route is the technology transfer office of a partner institution, or a direct approach through the contact routes on ipgroupplc.com. For Indian founders, the practical path is a research collaboration or spin-out relationship with a UK partner university, or a co-investment introduction via an existing portfolio company or university fund. Come with defensible intellectual property and a credible commercialisation plan, not just a research paper.

Why it matters for founders

For Indian deeptech founders, IP Group shows what patient university capital looks like: long partnerships, balance-sheet cheques and follow-on support to IPO. If your company is born from university research, a UK academic partnership is the door worth opening.